The Year in Cardiac Imaging  by Gibbons, Raymond J. & Araoz, Philip A.
YT
R
R
I
a
i
(
e
r
(
b
l
i
s
i
i
a
t
t
t
T
S
t
o
D
t
t
o
i
m
u
t
t
i
e
m
d
m
h
o
R
i
T
P
T
Journal of the American College of Cardiology Vol. 46, No. 3, 2005
© 2005 by the American College of Cardiology Foundation ISSN 0735-1097/05/$30.00
PEAR IN CARDIOLOGY SERIES
he Year in Cardiac Imaging
aymond J. Gibbons, MD,* Philip A. Araoz, MD†
ublished by Elsevier Inc. doi:10.1016/j.jacc.2005.05.065ochester, Minnesota
C
t
s
u
n
a
c
t
a
d
2
s
i
M
i
d
i
c
a
a
p
a
n
w
g
n
t
X
p
a
p
e
c
a
t
a
f
C
1
t
a
f
1
sn this sequel to our report last year, we have again
ttempted to highlight the most important recent literature
n single-photon emission computerized tomography
SPECT) myocardial perfusion imaging, cardiac positron
mission tomography (PET), cardiac computerized tomog-
aphy (CT), and cardiac magnetic resonance imaging
MRI). In almost all cases, these studies were published
etween May 31, 2004, and April 30, 2005, in the English-
anguage literature. We have once again had to arbitrarily
nclude some articles and exclude others in the interest of
pace. We apologize to those whose work we excluded or
nadvertently overlooked. The selection of the best literature
n any given year is certainly an inexact judgment. We have
gain organized this summary of the literature around
opical themes in an attempt to encourage the reader to
hink as broadly as possible about the application of imaging
o clinical problems.
ECHNICAL ADVANCES
PECT. Despite the maturity of SPECT imaging, impor-
ant technical advances continue. Hatada et al. (1) reported
n the use of a new technetium perfusion agent (N-
BODC5) in a rat model. The agent cleared rapidly from
he blood pool and had much more rapid liver clearance
han either sestamibi or tetrofosmin, suggesting that it may
ffer the potential for earlier imaging acquisition and less
nterference from hepatic uptake.
Abidov et al. (2) described the use of an automated
ethod to detect transient ischemic dilation in patients
ndergoing adenosine myocardial perfusion imaging. Pa-
ients with an abnormal automated transient ischemic dila-
ion ratio, first established in a pilot group and then tested
n the validation group, were more likely to have severe and
xtensive coronary artery disease (CAD).
Dupuis et al. (3) described a pilot study of a highly novel
ethod to quantify hyperemic forearm blood flow response
uring resting myocardial perfusion imaging using tetrofos-
in. The ratio of the maximum upslope in the two arms
ad modest sensitivity and specificity for the detection of
From the Division of Cardiovascular Diseases and Internal Medicine, *Department
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Manuscript received May 26, 2005; accepted May 31, 2005.AD but potentially offered an adjunctive measurement
hat could easily be added to existing imaging protocols.
Fricke et al. (4) examined 140 patients who underwent
estamibi SPECT imaging with attenuation correction
sing X-ray tomography. A total of 27 patients had pro-
ounced defects in the apical or anterior wall after attenu-
tion correction. Fricke et al. (4) examined these images
arefully for misalignment in the Y-direction. With correc-
ion of the misalignment, 21 of the 27 defects improved,
nd 6 resolved completely. Berman et al. (5) carefully
erived and validated a conversion algorithm to convert
0-segment perfusion scores to 17-segment perfusion
cores. This conversion model will be of considerable
nterest to investigators.
RI. The major recent advance in MRI has been the
ntroduction of 3-T scanners. These scanners were intro-
uced by the vendors in 2002 for clinical use and theoret-
cally are capable of producing twice as much signal as
onventional 1.5-T scanners. Some preliminary studies have
ttempted to use that increased signal to image the coronary
rteries (6,7), although these were early technical articles
erformed in volunteers. As is typically the case with MRI,
pplication of the new technology is being widely applied in
euroimaging, which is the easiest organ system to image
ith MRI. Cardiovascular applications will likely follow.
Another area of technological advance has been MRI-
uided interventions. Last year, several groups developed
ew technology that should make MRI-guided interven-
ions closer to a clinical reality. Rieke et al. (8) developed an
-ray–compatible radiofrequency coil that would allow a
atient to have the radiofrequency coil placed over the
natomy of interest while a fluoroscopic procedure was
erformed, which would make combined fluoroscopic/MRI
quipment more feasible. Kuehne et al. (9) placed resonant
ircuits on stents, which were implanted in large vessels in
nimals. The resonant circuits allowed MRI visualization of
he stents, which has previously been difficult with MRI. In
similar vein, Quick et al. (10) developed a wireless method
or catheters to emit signal detectable by MRI.
T. Technical advances in CT have been very rapid. Since
998, a new generation of scanner has been introduced every
wo years. Each generation of scanner has been marked by
n increase in the number of detector rows, which has led to
aster acquisitions and better spatial resolution. In 2002, the
6-detector row CT scanner became available. This scanner
howed acquisition times fast enough to allow for coronary
maging in very cooperative patients with very slow heart
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August 2, 2005:542–51 Year in Cardiac Imagingates. The coronary imaging produced with these scanners is
ot robust because it is successful only in select patients, but
t has sparked a dramatic increase in the literature examining
oronary computed tomography angiography (CTA), which
s described in the sections that follow. The vendors
ntroduced the 64-detector scanner in the fall of 2004.
lthough all of last year’s literature discussed the use of the
6-detector scanner, it is expected that next year’s literature
ill be dominated by new studies performed with the
4-detector scanners. However, although the 64-detector
canner is still brand new, there are reports in the literature
bout possible new scanners, at least of one which may use
flat-panel detector (11).
YOCARDIAL VIABILITY
PECT. Bax et al. (12) demonstrated the impact of severe
eft ventricular (LV) dilation on functional recovery after
evascularization in patients with viable myocardium by
PECT 18F-deoxyglucose (FDG) imaging. The change in
jection fraction after revascularization was linearly related
o baseline LV end-systolic volumes. Event rates during
ollow-up depended on both viable myocardium and LV
ize.
Slart et al. (13) compared resting tetrofosmin SPECT
nd FDG SPECT in 33 patients with CAD (CAD) and
V dysfunction. Of those segments judged viable on FDG
PECT, 89% were classified as viable by tetrofosmin
PECT. With attenuation correction, this percentage in-
reased to 96%.
ET. Rizzello et al. (14) published long-term follow-up in
6 patients with ischemic cardiomyopathy who underwent
evascularization. Most patients with viable myocardium by
able 1. Papers Evaluating MRI Delayed Enhancement in the S
Author (Ref.) N Treatment
Days
After MI Pred
aase et al. (17) 45 PCI 4–10 Absolute
% of LV
brahim et al. (18) 33 PCI 7.0  1.5 % of LV
ngkanisorn et al. (20) 33 23 with PCI 0–5 Absolute
20 with 5 months
follow-up
Transmu
und et al. (19) 60 47 with PCI 1–3 % of LV
12 with thrombolysis
edstrom et al. (21) 14 PCI 6–9 Absolute
% of LVK  creatine kinase; EF  ejection fraction; LV  left ventricular; MI  myocardia
ntervention; SPECT  single-photon emission computed tomography; Tl  thallium.ET had an increase in LV ejection fraction 12 months
fter surgery. Of those patients with an increased ejection
raction at 1 year, 93% had persistent improvement at 4.5
ears.
Hernandez-Pampaloni et al. (15) studied 116 patients
ith ischemic cardiomyopathy and ejection fraction 40%
y PET. Of 834 dysfunctional segments, 72% demonstrated
hronic stunning and only 9% demonstrated hibernation,
uggesting that chronic stunning is far more prevalent than
enerally realized.
Santana et al. (16) studied 90 patients with a mean
jection fraction of 26% and LV dysfunction due to CAD
y gated FDG PET. End-diastolic volume and end-systolic
olume assessed by PET both had greater prognostic value
han the ejection fraction. Patients with marked LV dilation
howed less improvement in heart failure symptoms with
evascularization.
RI. The most widely used MRI method for measuring
iability is one in which the patient is imaged approximately
0 min after the injection of MRI contrast material. The
ontrast washes out of normal myocardium but remains in
he interstitial space of infarcted myocardium so that the
nfarcted tissue displays “delayed enhancement” and appears
right.
Although this technique is widely accepted, most of the
iterature regarding delayed enhancement is based on animal
odels or on chronic infarctions in humans. Several studies
ompared MRI delayed enhancement in the acute myocar-
ial infarction (MI) setting to peak biochemical markers
17–20), nuclear medicine SPECT techniques (18,19,21),
r functional assessment (Table 1) (20). They reported
enerally good correlations with the different reference
of Acute MI
Variable Reference Standard Findings
rct size (g) Peak CK r  0.72, p  0.001
s infarcted Peak CK r  0.77, p  0.001
s infarcted 99mTc sestamibi SPECT r  0.86, mean difference
0.6  8%
Peak CK r  0.71, p  0.05
Acute LV EF r  0.58, p  0.05
rct size (g) Peak troponin I r  0.86, p  0.001
(for reperfused infarcts
only)
Acute LV EF r  0.66
5 months follow-up LV EF r  0.86, p  0.001
tent 5 months follow-up wall
thickening
p  0.001
s infarcted 201T1 SPECT r  0.73, mean difference
1.3  9.8%
Peak CK r  0.59, p  0.001
rct size (ml) 99mTc tetrofosmin SPECT Mean difference 8  8 ml,
p  0.002
me infarcted Mean difference 6  5%,
p  0.001etting
ictor
infa
mas
mas
infa
ral ex
mas
infa
volul infarction; MRI  magnetic resonance imaging; PCI  percutaneous coronary
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Year in Cardiac Imaging August 2, 2005:542–51tandards, suggesting that delayed enhancement MRI has
otential as a surrogate outcome measure of infarct size.
T. In contrast to SPECT, PET, and MRI, viability with
T is in a very developmental stage. Because CT contrast
aterial is cleared by the same mechanisms as MRI contrast
aterial, a CT “delayed-enhancement” approach is possible.
n 58 patients studied at 2 days, 28 days, and 1 year after
I, Koyama et al. (22) found CT-delayed enhancement in
6 (62%) of the patients. Wall thickening at follow-up was
ignificantly less for patients with this finding than for those
ithout. Although this study was limited by small patient
umbers and the lack of a gold standard, it suggested that a
elayed enhancement technique might be applicable with CT.
ARDIAC RESYNCHRONIZATION THERAPY (CRT)
ET. Lindner et al. (23) compared 31 study patients with
evere dilated cardiomyopathy and left bundle branch block
ith 14 control patients who had mild-to-moderate dilated
ardiomyopathy without left bundle branch block. The
atients showed a heterogeneous distribution of both
VO2 and myocardial blood flow, both of which were
ncreased in the lateral wall. The control group did not show
hese differences.
Knuuti et al. (24) studied the right ventricle in 10 patients
ith idiopathic dilated cardiomyopathy who had undergone
RT. They reported a significant correlation (R  0.66,
 0.03) between Kmono in the right ventricle and LV
troke volume response to CRT, as well as an increase in
ight ventricular oxidative metabolism with CRT during
obutamine-induced stress.
O’Neill et al. (25) examined 44 patients with nonischemic
ilated cardiomyopathy. Evidence of scarring was found,
sing PET, in 91% of the patients, involving a mean of 25%
f the LV, predominantly in the left anterior descending
rtery distribution. The QRS duration correlated positively
ith the degree of scarring. The authors suggested that
ardiac resynchronization therapy might be less effective in
he presence of such scarring and suggested the need for
urther studies.
RI. There is a small-but-growing amount of literature
uggesting that MRI might be safely performed on patients
ith pacemakers. Few studies have examined the safety of
mplantable cardioverter defibrillators (ICDs) in an MRI
nvironment. To fill this gap, Roguin et al. (26) studied 17
CD and 9 pacemaker models both in vitro (in gel phan-
oms) and in vivo (in dogs). They evaluated the different
evices for heating, force exerted by the magnetic field, and
unction after scanning.
Although they found some lead-tip heating and some
orce acting upon the devices, the authors felt these were not
ignificant for pacemakers and for ICDs manufactured after
he year 2000. Because ICDs interpreted the magnetic field
s an arrhythmia, the authors suggested, ICDs should be set
o “monitor-on/therapy-off” mode during MRI. Several
CD models were irreversibly damaged and could not be bubsequently interrogated. Finally, there were minor bat-
ery, parameter, and memory changes in some of the
emaining ICDs. They recommended that models that were
amaged or underwent even minor battery changes should
ot undergo MRI.
In contrast to ICDs, they found that the MRI field
id not modify function for pacemakers. They concluded
hat MRI of the pacemakers studied was safe, although
hey recommended setting pacemakers to VOO for
acemaker-dependent patients and to ODO for nonde-
endent patients. Nevertheless, the authors cautioned
hat their findings might not be completely applicable in
umans and applied only to the ICD and pacemaker
odels studied.
AD
iagnosis. SPECT. Danias et al. (27) used gated SPECT
maging to identify underlying CAD in 164 patients with an
jection fraction of 40%. The combined assessment of
erfusion, reversibility, and regional wall motion had a
elatively high sensitivity of 94% but a poor specificity of
nly 45%. A negative SPECT study might therefore elim-
nate the need for coronary angiography.
Hauser et al. (28) carefully examined the relationship
etween ST-segment depression during exercise and the
agnitude of myocardial ischemia by SPECT imaging in
,006 patients. The magnitude of ST-segment depression,
he number of leads with ST-segment depression, and the
ccurrence of ST-segment depression at a low exercise
orkload were all highly associated with the magnitude of
schemia assessed by the summed stress score, confirming
hat ST-segment depression is caused by ischemia.
Akinboboye et al. (29) studied bicycle and mental stress
esting in 58 patients with CAD. Mental stress ischemia
as more frequent in patients with severe LV dysfunction
han in those with normal LV function, suggesting that
ental stress may be of particular importance in patients
ith LV dysfunction.
Aboul-Enein et al. (30) examined the impact of collat-
rals in patients with single-vessel chronic total occlusion
nd no previous MI. Resting wall motion abnormalities
ere more frequent in those with poor collaterals. Severe
nd extensive stress SPECT perfusion defects were similar
n patients with excellent collaterals and poor collaterals.
esting perfusion was near-normal in both groups, indicat-
ng that wall motion abnormalities were likely due to
hronic stunning rather than hibernation.
Mowatt et al. (31) reported a systematic review of the
ffectiveness and cost-effectiveness of myocardial perfusion
maging for CAD for the United Kingdom National Health
ervice. This extensive, lengthy document emphasized the
eed for further research regarding both gated and
ttenuation-corrected SPECT.
ET. Mishra et al. (32) carefully examined the relationship
etween changes in myocardial blood flow as assessed by
N
b
h
p
c
o
r
r
s
M
s
i
a
c
d
a
i
d
p
w
b
s
b
e
i
t
C
g
d
p
a
t

i
1
r
l
t
n
i
B
p
m
2
5
F ssure
a
F
e
D
545JACC Vol. 46, No. 3, 2005 Gibbons and Araoz
August 2, 2005:542–51 Year in Cardiac Imaging-13 ammonia with PET and changes in heart rate and
lood pressure during adenosine infusion. The change in
eart rate and change in blood pressure were extremely poor
redictors of coronary flow reserve; the greatest correlation
oefficient was only R  0.11. Thus, the common practice
f using heart rate and blood pressure to assess adenosine
esponse is ill-advised (Fig. 1).
Chow et al. (33) demonstrated the feasibility of exercise
ubidium PET imaging. Compared with dipyridamole
tress, exercise image quality was superior.
RI: FUNCTIONAL DETECTION OF CAD. With MRI, perfu-
ion imaging and wall motion assessment can be performed
n the same examination, as Paetsch et al. (34) reported in
study of 79 patients referred for clinically indicated cardiac
atheterization. Before catheterization, these patients un-
erwent a complex MRI examination, which included
denosine stress perfusion imaging, rest wall motion imag-
ng, adenosine stress wall motion imaging, and high dose
obutamine stress wall motion imaging, which all were
erformed in the same examination. Cardiac catheterization
as the gold standard, with any 50% or greater stenosis
eing considered a positive result.
Dobutamine stress wall motion assessment had the best
ensitivity and accuracy, both of which were significantly
etter than adenosine perfusion (Fig. 2). Although stress
chocardiographers might find these results encouraging, it
s unclear whether the findings in this study might translate
o other modalities.
T: CORONARY CALCIUM SCANNING. Two articles investi-
ated the relationship between atherosclerotic burden as
etected by CT coronary calcium scanning and myocardial
erfusion abnormalities as detected by SPECT. Anand et
igure 1. Correlation between change in heart rate and change in blood pre
mmonia. From Mishra et al. (32).l. (35) studied 220 asymptomatic patients with moderate-
m
ao-severe amounts of coronary calcium (Agatston score
100), who all underwent SPECT myocardial perfusion
maging. They discovered that SPECT was abnormal in
8% of patients with moderate levels of calcium (scores
anging from 100 to 399) and in 45% of patients with severe
evels of calcium (scores 400).
Berman et al. (36) retrospectively studied 1,195 pa-
ients who underwent both CT coronary calcium scan-
ing and myocardial perfusion scanning for clinical
ndications. In contrast to the study by Anand et al. (35),
erman et al. included patients with low scores and
atients with symptoms (49% of the study group). Ber-
an et al. reported a lower frequency of abnormal scans:
% of patients with mild levels of calcium (scores 100),
% of patients with moderate levels of calcium (scores
during adenosine with changes in myocardial blood flow assessed by N-13
igure 2. Sensitivity and specificity of perfusion and wall motion param-
ters obtained from a single magnetic resonance imaging examination.
obutamine stress wall motion assessment had the best diagnostic perfor-
ance. Open bars  sensitivity; solid bars  specificity. From Paetsch et
l. (34).
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Year in Cardiac Imaging August 2, 2005:542–51anging from 100 to 399), 9% of patients with more
evere scores (400 to 999), and 20% of patients with the
ost severe scores (1,000) (Fig. 3).
Anand et al. (35) suggested that clinicians should con-
ider both the calcium score and clinical parameters before
eferring patients to perfusion imaging. However, Berman
t al. (36) concluded that perfusion imaging generally is not
ndicated for patients with a coronary calcium score 100
nd that clinical parameters have the most impact on the
ecision to proceed with perfusion imaging for patients with
cores ranging from 100 to 400. Both authors felt that high
alcium scores (400) warranted consideration for myocar-
ial perfusion scanning.
T: NONINVASIVE ANGIOGRAPHY. The most recent gener-
tion of scanner, the 16-detector scanner introduced in
002, has made coronary CTA feasible in select patients. In
able 2, we list the studies to date comparing 16-detector
oronary CTA with cardiac catheterization. We have only
ncluded studies that were prospective and in which 16-
etector coronary CTA was performed before cardiac cath-
terization (37–46).
Although many of the studies excluded segments that
ere considered not analyzable, overall the results are
ncouraging; coronary CTA appears to have high specificity
nd good negative predictive value (Fig. 4A). However,
ome caveats are in order.
First, a low burden of coronary calcium is important for
iagnostic images. For a variety of technical reasons, cal-
ium appears to occupy an artifactually large space on CT
mages (Fig. 4B). For this reason, calcium outside the lumen
ay appear to cause a stenosis, and most reports cite
oronary calcification as a major source of false-positive
esults. Because coronary calcium increases with age, it is
mportant to note that all of the studies enrolled relatively
oung patients.
Second, low heart rates are required for diagnostic im-
ges. In all of the studies, patients were given beta blockers
igure 3. Frequency of ischemic single-photon emission computerized to-
ography myocardial perfusion scan (open bars) and of a moderately-to-
everely ischemic scan (solid bars) for patients divided into six groupings based
n the coronary artery calcium (CAC) score. From Berman et al. (36).o slow the heart rate, and in one study (45) patients with Ta
b
R
o
M
o
H
o
K
u
M
o
K
u
M
o
C
a
H
e
H
o
Fo
r
se
gm
1
to N
h
h
l
w
c
a
(
p
t
r
a
P
T
n
t
s
i
e
f
p
f
t
r
s
f
v
e
a
t
p
r
p
s
S
p
F
t
p
T
s
m
E
l
r
s (b). F
t s is ov
547JACC Vol. 46, No. 3, 2005 Gibbons and Araoz
August 2, 2005:542–51 Year in Cardiac Imagingeart rate 65 beats/min were excluded. Despite the low
eart rates in these studies, image blurring was still a
imiting factor, especially in the right coronary artery (42).
Third, the examination requires a cooperative patient
ho can hold his or her breath. All of the studies listed used
linically stable patients. Mollet et al. (39) required an
dequate breath-hold as an inclusion criteria. Kuetner et al.
41) excluded one patient because the patient did not
erform an adequate breath-hold during scanning. Given
hese caveats, CT may prove to be less useful in the highest
isk patients—the elderly, the unstable, the uncooperative—
nd may be most useful in a lower risk group.
rognosis. SINGLE-PHOTON EMISSION COMPUTERIZED
OMOGRAPHY. Elhendy et al. (47) demonstrated the prog-
ostic significance of peri-infarction ischemia in 345 pa-
ients with previous MI. Peri-infarction ischemia was a
urprisingly better prognostic indicator than remote
schemia.
Liao et al. (48) reported on 997 patients who underwent
igure 4. (A) True-positive 16-detector coronary computed tomography a
he proximal left anterior descending (LAD) (arrow). (b) A cross section t
laque obstructing much of the lumen (arrow). A small residual lumen with
he axial image is overlaid in the lower left-hand corner and the plane of
tenosis (75% diameter, arrow) corresponds to the plaque observed at CT
ultiplanar reformat of the CT data, intended to display the LAD in a pro
xtensive calcification can be found along the course of the LAD artery. Pro
ine. (b) A cross section of the vessel (the plane defined by the line in a). The
eplaced with calcified plaque. (c) A catheter angiogram. At the site of th
tenosis but not the occlusion, as shown on the CT images from (a) and
han it does in reality. For this reason, stenosis caused by calcified plaquexercise SPECT imaging and also had first-pass ejection (raction measured at peak exercise. They evaluated the
rognostic power of the Duke treadmill score, peak ejection
raction, and the summed stress score. Although each of the
hree parameters was univariately significant, in clinical
isk-adjusted models, first-pass ejection fraction was clearly
uperior to either the treadmill score or summed stress score
or the prediction of cardiovascular death.
Azarbal et al. (49) reported on the potential prognostic
alue of chronotropic incompetence in patients undergoing
xercise SPECT. The percent heart rate reserve achieved
dded to the severity of SPECT abnormality in the predic-
ion of cardiac death. The authors concluded that this
arameter should be incorporated into routine clinical
eporting and risk stratification algorithms.
Navare et al. (50) reported a meta-analysis of 14,918
atients from 24 studies evaluating the prognosis of patients
tudied with either pharmacologic or exercise stress
PECT. The analysis showed higher annual event rates in
atients with normal images after pharmacologic stress
raphy (CTA). (a) Axial images show a calcified and uncalcified plaque in
h the plaque shows calcium on the periphery and a low-attenuation, soft
rast is visible at approximately the one-o’clock position in the vessel lumen.
ross section is shown (line). (c) Catheter angiography shows an eccentric
Ropers et al. (38). (B) False-positive 16-detector coronary CTA. (a) A
n equivalent to a right anterior oblique projection at catheter angiography.
lly, there is a heavily calcified plaque, which is shown bisected with a white
section is entirely white, meaning it appears the vessel lumen is completely
ified plaque shown in (a) and (b) (line bisecting the LAD), there is mild
or technical reasons, calcium appears to occupy more space on CT scans
erestimated by CT. From Hoffmann et al. (40).ngiog
hroug
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Year in Cardiac Imaging August 2, 2005:542–51eported higher event rates with abnormal tests after phar-
acologic stress compared with exercise stress. These dif-
erences appeared to reflect the different intrinsic risk of the
wo patient populations.
Hachamovitch et al. (51) derived and validated an algo-
ithm for predicting cardiac death after adenosine SPECT.
heir models, including age, percent ischemic myocardium
y SPECT, percent fixed myocardium by SPECT, dyspnea,
est heart rate, peak heart rate, and resting electrocardio-
ram (ECG) abnormalities, suggested the importance of all
f these parameters in test interpretation.
pecial patient groups. ACUTE CHEST PAIN TRIAGE. Ka-
etanopoulos et al. (52) reported on 341 diabetic patients in
substudy of the Emergency Room Assessment of Sesta-
ibi for the Evaluation of Chest Pain (ERASE Chest Pain)
rial. Acute triage of chest pain using resting myocardial
erfusion imaging appeared to be just as effective in diabetic
atients as in nondiabetic patients.
Kaul et al. (53) reported the results of a multicenter study
mploying contrast echocardiography and gated SPECT in
cute chest pain assessment in 205 patients. Both imaging
tudies offered diagnostic and prognostic information that
as incremental to clinical and electrocardiographic
ssessment.
IABETES MELLITUS. Wackers et al. (54) reported baseline
ndings from the Detection of Ischemia in Asymptomatic
iabetics (DIAD) study. In 522 patients randomized to
tress testing, 113 patients (22%) had silent ischemia,
ncluding 83 with SPECT perfusion defects, of whom 33
ad moderate or large perfusion defects. This study added
o the growing evidence of silent CAD in middle-aged
iabetics.
Rajagopalan et al. (55) reported clinical and laboratory
orrelates of high-risk SPECT scans in 1,427 asymptomatic
atients with diabetes. High-risk scans, which occurred in
8% of the patients, were associated with seven different
ariables on multivariate analysis, the most important of
hich were ECG Q waves and peripheral arterial disease.
ESTING ECG ABNORMALITIES. Kwok et al. (56) demon-
trated the incremental prognostic value of exercise
hallium-201 SPECT in 939 patients with nonspecific ST-
nd T-wave abnormalities on their resting ECG. Most of
he incremental prognostic value of SPECT was in those
atients who were classified as intermediate-risk on the
asis of clinical and exercise ECG parameters.
LDERLY PATIENTS. Schinkel et al. (57) demonstrated the
rognostic value of dobutamine tetrofosmin SPECT in 272
atients older than 65 years of age. Abnormal scan findings
dded significantly to clinical data, and identified low-risk
nd high-risk subsets. Valeti et al. (58) examined 274
atients 75 years or older with exercise thallium-201
PECT. The summed stress score by SPECT classified
ost patients into useful low- and high-risk categories and
as much more effective than the Duke treadmill score. ionitoring of therapy. Tio et al. (59) carefully studied 35
atients with end-stage CAD who were randomized to
herapy with vascular endothelial growth factor, endomyo-
ardial laser therapy, or conventional medical therapy. Using
uantitative N-13 ammonia PET imaging, stress perfusion
mproved in the ischemic area with vascular endothelial
rowth factor therapy. Most noteworthy in this study was
he ability to demonstrate a therapeutic benefit in a very
mall number of patients.
Mahmarian et al. (60) described the design and baseline
haracteristics of the Adenosine Sestamibi SPECT Post-
nfarction Evaluation (INSPIRE) trial, a randomized, pro-
pective multicenter trial using sestamibi SPECT for risk
ssessment after acute MI. Dobert et al. (61) examined
yocardial perfusion with both PET and SPECT in 15
atients who received intracoronary bone marrow derived
ells and 11 patients who received intracoronary blood-
erived endothelial progenitor cells after MI. They demon-
trated an increase in signal intensity in the infarct zone by
oth PET and SPECT, but there were no controls in this
tudy.
V FUNCTION
PECT. Liu et al. (62) performed an extensive phantom
nd patient validation of a new quantitative method for
ated SPECT. Their technique showed very close agree-
ent (R  0.90; SEE  6.2%) with ejection fraction
easured by equilibrium radionuclide angiography.
RI. Although different types of cardiac function are
easurable with MRI, notably flow measurements in large
essels, the main functional assessment performed with
RI is the measurement of cardiac volumes. In much of the
iterature involving both MRI and cardiac volumes, MRI is
ow used as a gold standard against which other methods
ere measured. Last year, MRI was used in this manner in
tudies of three-dimensional echocardiography (63), con-
rast echocardiography (64), and CT (discussed in the
ollowing section).
One limitation of MRI for cardiac volumes is that the
rocedure is relatively slow. Currently, the acquisition of each
natomic level typically requires a separate breath-hold. Cov-
rage of the whole heart usually takes 10 to 12 breath-holds,
hich may be difficult for some patients. A faster, near
eal-time acquisition would be desirable. In a small study,
eters tested such an acquisition (65). In 10 healthy volunteers
hey performed the standard, multibreath-hold acquisition and
novel, faster single breath-hold acquisition. Using Bland-
ltman analysis, the mean difference in LV ejection fraction
etween the techniques was small (0.6%), although the 95%
onfidence intervals of this difference were considerable
7.7%).
T. The main limitation of CT for functional imaging is
hat a bolus of contrast is required to distinguish the
yocardium from the ventricular cavity. This bolus usuallys visible for only a minute; therefore, all the required data
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August 2, 2005:542–51 Year in Cardiac Imagingust be acquired in that time. Unlike SPECT, PET, and
RI, which can use many beats to acquire images, CT
equires extremely fast acquisitions.
These types of acquisitions are just recently becoming
vailable. Five studies compared LV volumes, measured by
6-detector CT, to a gold standard (Table 3) (66–70). The
nitial results look very good, with excellent correlation
oefficients and mean differences between CT and the gold
tandard, which were consistently 2%.
OLECULAR IMAGING
s we indicated last year, the numerous papers in this field
overing an enormous range of topics are well beyond the
cope of this article. We have again chosen a few articles as
xamples of this rich literature.
ET. Wu et al. (71) demonstrated the feasibility of mo-
ecular imaging with microPET in a rat model to monitor
ngiogenic gene expression with PET reporter genes. Car-
iac transgene expression peaked at one day and declined
ver the next two weeks. The in vivo PET reporter gene
xpression correlated closely with ex vivo gamma counting
s well as myocardial tissue enzyme activity.
Miyagawa et al. (72) compared two approaches to PET
eporter gene imaging, a wild-type herpes simplex virus type
thymidine kinase (HSV1-tk) gene labeled with an iodine-
24 iodouracil and a mutant HSV1-tk gene labeled with a
uorine-18-labeled guanine. The fluorine-labeled reporter
ene appeared to be superior on the basis of continuous
ccumulation over time and a better imaging contrast.
RI. To date, most MRI-based molecular imaging meth-
ds use one of two approaches: cell labeling with iron, and
ntibody labeling with nanoparticles. In the cell-labeling
ethod, iron (which is detectable by MRI) is phagocytized
nto cells, usually stem cells, which are then tracked. The use
f this method is rapidly increasing because the iron
articles are commercially available and the labeling proce-
ure is not difficult. One study was an excellent example of
areful cell labeling methods, even though the authors did
ot study the cardiovascular system (73). Bos et al. (73)
arefully described the iron content per cell and how iron
oading affected cellular proliferation and differentiation.
he authors studied the in vitro relationship between cell
oncentration and MRI signal, showed the time course of
ptake of the cells, and validated their results with histology.
able 3. 16-Detector Computed Tomography for Left Ventricula
Author (Ref.) N Gold Standard
Mean
Stan
och et al. (66) 19 MRI
oche et al. (67) 10 MUGA
euschmid et al. (68) 31 MRI
ahnken et al. (69) 21 MRI
chlosser et al. (70) 18 MRI
Coche and Mahnken reported the variability in the form of Bland-Altman plots. Th
arenthesis are the two standard deviation values for the overestimation and underes
CI  confidence interval; MUGA  multigated acquisition radionuclide ventricuIn the antibody method, investigators create a particleoften called a nanoparticle) that binds to a target of interest
nd also gives off a detectable signal. Compared with
hagocytotic cell labeling, nanoparticle creation is very
ifficult. However, once created, nanoparticles may contain
any, sometimes thousands, of signal-generating compo-
ents and also can be specifically targeted. For example, in
n early, technical communication, Frias et al. (74) reported
he creation of a high-density lipoprotein-like nanoparticle
hat could contain either 15 to 20 particles of MRI contrast
aterial or fluorescent phospholipids (74). Kelly et al. (75)
reated a particle that targeted vascular adhesion
olecule-1, which contained both MRI contrast agents and
uorescent particles. Using this particle, they were able to
etect this particle in atherosclerotic plaques in an animal
odel.
ONCLUSIONS
e hope that this review has successfully highlighted some
f the most important new literature in cardiac imaging and
timulated you the reader to examine at least a few of the
riginal articles in detail.
eprint requests and correspondence: Dr. Raymond J. Gibbons,
ayo Clinic, Gonda 5, 200 First Street, SW, Rochester, Minne-
ota 55905. E-mail: gibbons.raymond@mayo.edu.
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